Trial · NCT00775684
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Exenatide | Acute Insulin Response (AIRmax)Baseline | 214 | Standard Error 60 | μU/ml |
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Sitagliptin | Acute Insulin Response (AIRmax)Baseline | 149 | Standard Error 20 | μU/ml |
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Glimepiride | Acute Insulin Response (AIRmax)Baseline | 133 | Standard Error 19 | μU/ml |
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Exenatide | Acute Insulin Response (AIRmax) 6 Months | 188.5 | Standard Error 34.6 | μU/ml |
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Sitagliptin | Acute Insulin Response (AIRmax) 6 Months | 158.3 | Standard Error 30.3 | μU/ml |
| Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) | Glimepiride | Acute Insulin Response (AIRmax) 6 Months | 202.5 | Standard Error 35.1 | μU/ml |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Exenatide | Acute Insulin Response (AIRarg) Baseline | 52 | Standard Error 14 | uU/mL |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Sitagliptin | Acute Insulin Response (AIRarg) Baseline | 35 | Standard Error 4 | uU/mL |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Glimepiride | Acute Insulin Response (AIRarg) Baseline | 44 | Standard Error 6 | uU/mL |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Exenatide | Acute Insulin Response (AIRarg) 6 Months | 52 | Standard Error 11 | uU/mL |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Sitagliptin | Acute Insulin Response (AIRarg) 6 Months | 34 | Standard Error 6 | uU/mL |
| Change in Acute Insulin Response to Arginine. (AIRarg) | AIRarg Glimepiride | Acute Insulin Response (AIRarg) 6 Months | 42 | Standard Error 4 | uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Exenatide | M/I Baseline | 0.3 | Standard Error 0.1 | ((mg/kg) /min) /uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Sitagliptin | M/I Baseline | 0.3 | Standard Error 0.0 | ((mg/kg) /min) /uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Glimepiride | M/I Baseline | 0.3 | Standard Error 0.1 | ((mg/kg) /min) /uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Exenatide | M/I 6 Months | 0.3 | Standard Error 0.1 | ((mg/kg) /min) /uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Sitagliptin | M/I 6 Months | 0.3 | Standard Error 0.1 | ((mg/kg) /min) /uU/mL |
| Insulin Sensitivity at Baseline and 6 Months | M/I Glimepiride | M/I 6 Months | 0.3 | Standard Error 0.1 | ((mg/kg) /min) /uU/mL |
| PG 50 (the Plasma Glucose Level at Which Half-maximal Insulin Secretion is Achieved During the Glucose-potentiated Arginine Test) at Baseline and 6 Months | P50 Exenatide | PG50 Baseline | 175 | Standard Error 13 | mg/dL |
| PG 50 (the Plasma Glucose Level at Which Half-maximal Insulin Secretion is Achieved During the Glucose-potentiated Arginine Test) at Baseline and 6 Months | P50 Sitagliptin | PG50 Baseline | 226 | Standard Error 12 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00775684/results